Viewing Study NCT02124668

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:54 PM
Ignite Modification Date: 2026-03-01 @ 5:00 PM
Study NCT ID: NCT02124668
Status: COMPLETED
Last Update Posted: 2024-11-21
First Post: 2014-04-25
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
Sponsor: Astellas Pharma Europe B.V.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Castration-Resistant Prostate Cancer View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Xtandi View
None MDV3100 View
None Progressive Castration-Resistant Prostate Cancer View
None Enzalutamide View